Skip to content


Teysuno (tegafur) is a small molecule pharmaceutical. Tegafur was first approved as Teysuno on 2011-03-14. It has been approved in Europe to treat stomach neoplasms. It is known to target dihydropyrimidine dehydrogenase [NADP(+)].
Trade Name Teysuno
Common Name Tegafur
Indication stomach neoplasms
Drug Class
Get full access now